PEG-Asparaginase Single-Agent Rescue in an Advanced Case of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma.

Emiliano BarbieriStefano PozziRoberta GelminiLuca RoncatiMonica MaccaferriLeonardo PotenzaRoberto MarascaMario LuppiGiovanna Leonardi

Published in: Journal of gastrointestinal cancer (2022)

The case we described brings new evidences on the effectiveness of PEG-asparaginase therapy in MEITL patients. Whether PEG-asparaginase should be included in the treatment course of MEITL patients could be the subject of future studies.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
drug delivery
randomized controlled trial
prognostic factors
systematic review
mesenchymal stem cells